BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
88.17
-0.96 (-1.08%)
At close: Oct 30, 2026, 4:00 PM EDT
88.05
-0.12 (-0.13%)
After-hours: Oct 30, 2026, 7:51 PM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $22.15 billion as of October 30, 2026. It is the 1,091st most valuable company in the world and the 455th biggest in the United States. Its market cap has decreased by 10.85% in one year.
Market Cap
22.15B
Enterprise Value
7.13B
1-Year Change
-10.85%
Global Rank
Country Rank
#455 United States
Category
ChartMarket Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $22.15B, an increase of 639.53%. That is a compound annual growth rate of 32.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 22.15B | -3.24% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genmab | 34.92B |
| Roivant Sciences | 26.66B |
| Insmed | 24.70B |
| Incyte | 24.54B |
| Alnylam Pharmaceuticals | 22.10B |
| Exelixis | 17.19B |
| Ascendis Pharma | 16.50B |
| Halozyme Therapeutics | 14.86B |